The autoimmune manifestations associated with myelodysplastic syndrome respond to 5‐azacytidine: a report on three cases

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 153; no. 5; pp. 664 - 665
Main Authors Pilorge, Sylvain, Doleris, Luc Moulonguet, Dreyfus, François, Park, Sophie
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2011
Blackwell
Subjects
5‐azacytidine
Aged
Autoimmune Diseases - drug therapy
auto‐immune disease
Azacitidine - therapeutic use
Biological and medical sciences
Hematologic and hematopoietic diseases
Humans
Immunologic Factors - therapeutic use
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
MDS
Medical sciences
Middle Aged
Myelodysplastic Syndromes - drug therapy
new drugs for leukaemia
therapy
Antineoplastic agent
Autoimmunity
Drug
Immunopathology
Hematology
Leukemia
therapy
5-azacytidine
Autoimmune disease
Malignant hemopathy
Myelodysplastic syndrome
Case study
Azanucleoside
Treatment
Antimetabolic
Azacitidine
Triazine derivatives
new drugs for leukaemia
MDS
auto-immune disease
Cancer
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-1048
1365-2141
DOI:10.1111/j.1365-2141.2010.08557.x